Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma.

Xuyin Z, Jingxin D, Xiang T, Luoqi J, Keqin H.

Oncol Lett. 2012 Nov;4(5):1008-1012. Epub 2012 Aug 23.

2.

Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.

Kurman RJ.

Ann Oncol. 2013 Dec;24 Suppl 10:x16-21. doi: 10.1093/annonc/mdt463. Review.

PMID:
24265397
3.

[Fallopian tube: the dark face of pelvic carcinogenesis].

Watkin E, Devouassoux-Shisheboran M.

Ann Pathol. 2011 Oct;31(5):345-52. doi: 10.1016/j.annpat.2011.06.008. Epub 2011 Sep 25. Review. French.

PMID:
21982240
4.

Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.

Patrono MG, Iniesta MD, Malpica A, Lu KH, Fernandez RO, Salvo G, Ramirez PT.

Gynecol Oncol. 2015 Dec;139(3):568-72. doi: 10.1016/j.ygyno.2015.09.018. Epub 2015 Sep 25. Review.

PMID:
26407480
5.

Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.

Li HX, Lu ZH, Shen K, Cheng WJ, Malpica A, Zhang J, Wei JJ, Zhang ZH, Liu J.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):848-57. eCollection 2014. Review.

6.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Vang R, Shih IeM, Kurman RJ.

Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Review.

PMID:
23240669
7.

Precursors and pathogenesis of ovarian carcinoma.

Lim D, Oliva E.

Pathology. 2013 Apr;45(3):229-42. doi: 10.1097/PAT.0b013e32835f2264. Review.

PMID:
23478230
8.

STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis.

Mehra K, Mehrad M, Ning G, Drapkin R, McKeon FD, Xian W, Crum CP.

Front Biosci (Elite Ed). 2011 Jan 1;3:625-34. Review.

PMID:
21196340

Supplemental Content

Support Center